Integer (ITGR) Competitors

$87.70 +1.41 (+1.63%)

Closing price 03:59 PM Eastern

Extended Trading

$87.92 +0.23 (+0.26%)

As of 04:10 PM Eastern

ITGR vs. BDSX, ELV, MASI, BAX, and TFX

Should you be buying Integer stock or one of its competitors? The main competitors of Integer include Biodesix (BDSX), Elevance Health (ELV), Masimo (MASI), Baxter International (BAX), and Teleflex (TFX). These companies are all part of the "medical" sector.

How does Integer compare to Biodesix?

Integer (NYSE:ITGR) and Biodesix (NASDAQ:BDSX) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings.

: Integer has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Integer $1.85B 1.61 $102.81M $4.01 21.87
Biodesix $88.50M 1.77 -$35.26M -$4.06 N/A
: In the previous week, Integer had 2 more articles in the media than Biodesix. MarketBeat recorded 11 mentions for Integer and 9 mentions for Biodesix. Biodesix's average media sentiment score of 0.27 beat Integer's score of 0.02 indicating that Biodesix is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Integer
3 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Biodesix
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
2 Very Negative mention(s)
Neutral
: Integer has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500. Comparatively, Biodesix has a beta of 0.43, indicating that its stock price is 57% less volatile than the S&P 500.
: Integer presently has a consensus target price of $98.29, suggesting a potential upside of 12.08%. Biodesix has a consensus target price of $33.00, suggesting a potential upside of 113.32%. Given Biodesix's stronger consensus rating and higher probable upside, analysts plainly believe Biodesix is more favorable than Integer.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integer
0 Sell rating(s)
6 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
2.40
Biodesix
1 Sell rating(s)

0 Hold rating(s)

5 Buy rating(s)

0 Strong Buy rating(s)
2.67
: 99.3% of Integer shares are owned by institutional investors. Comparatively, 21.0% of Biodesix shares are owned by institutional investors. 1.1% of Integer shares are owned by insiders. Comparatively, 23.2% of Biodesix shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
: Integer has a net margin of 7.64% compared to Biodesix's net margin of -33.26%. Integer's return on equity of 12.83% beat Biodesix's return on equity.
Company Net Margins Return on Equity Return on Assets
Integer 7.64% 12.83% 6.51%
Biodesix -33.26% -2,101.40% -35.65%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.85B	1.61	$102.81M	$4.01	21.87
Biodesix	$88.50M	1.77	-$35.26M	-$4.06	N/A

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	3 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Biodesix	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.40
Biodesix	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67

Company	Net Margins	Return on Equity	Return on Assets
Integer	7.64%	12.83%	6.51%
Biodesix	-33.26%	-2,101.40%	-35.65%

Summary

Integer beats Biodesix on 10 of the 16 factors compared between the two stocks.

How does Integer compare to Elevance Health?

Elevance Health (NYSE:ELV) and Integer (NYSE:ITGR) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, media sentiment, risk, profitability and institutional ownership.

: Elevance Health has higher revenue and earnings than Integer. Elevance Health is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Elevance Health $199.13B 0.41 $5.66B $23.51 15.86
Integer $1.85B 1.61 $102.81M $4.01 21.87
: In the previous week, Elevance Health had 13 more articles in the media than Integer. MarketBeat recorded 24 mentions for Elevance Health and 11 mentions for Integer. Elevance Health's average media sentiment score of 1.14 beat Integer's score of 0.02 indicating that Elevance Health is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elevance Health
13 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Integer
3 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
: 89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 0.3% of Elevance Health shares are owned by company insiders. Comparatively, 1.1% of Integer shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
: Elevance Health has a beta of 0.66, indicating that its stock price is 34% less volatile than the S&P 500. Comparatively, Integer has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500.
: Elevance Health currently has a consensus price target of $384.58, indicating a potential upside of 3.12%. Integer has a consensus price target of $98.29, indicating a potential upside of 12.08%. Given Integer's higher probable upside, analysts clearly believe Integer is more favorable than Elevance Health.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elevance Health
0 Sell rating(s)
10 Hold rating(s)

13 Buy rating(s)

0 Strong Buy rating(s)
2.57
Integer
0 Sell rating(s)

6 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
2.40
: Integer has a net margin of 7.64% compared to Elevance Health's net margin of 2.62%. Elevance Health's return on equity of 15.58% beat Integer's return on equity.
Company Net Margins Return on Equity Return on Assets
Elevance Health 2.62% 15.58% 5.57%
Integer 7.64% 12.83% 6.51%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elevance Health	$199.13B	0.41	$5.66B	$23.51	15.86
Integer	$1.85B	1.61	$102.81M	$4.01	21.87

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elevance Health	13 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Integer	3 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elevance Health	0 Sell rating(s)	10 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.57
Integer	0 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.40

Company	Net Margins	Return on Equity	Return on Assets
Elevance Health	2.62%	15.58%	5.57%
Integer	7.64%	12.83%	6.51%

Summary

Elevance Health and Integer tied by winning 8 of the 16 factors compared between the two stocks.

How does Integer compare to Masimo?

Masimo (NASDAQ:MASI) and Integer (NYSE:ITGR) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation and institutional ownership.

: Integer has a net margin of 7.64% compared to Masimo's net margin of 4.90%. Masimo's return on equity of 31.33% beat Integer's return on equity.
Company Net Margins Return on Equity Return on Assets
Masimo 4.90% 31.33% 13.93%
Integer 7.64% 12.83% 6.51%
: Masimo presently has a consensus price target of $180.40, indicating a potential upside of 1.06%. Integer has a consensus price target of $98.29, indicating a potential upside of 12.08%. Given Integer's stronger consensus rating and higher possible upside, analysts clearly believe Integer is more favorable than Masimo.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Masimo
0 Sell rating(s)
9 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
2.00
Integer
0 Sell rating(s)

6 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
2.40
: Integer has higher revenue and earnings than Masimo. Masimo is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Masimo $1.53B 6.12 -$151.50M -$10.54 N/A
Integer $1.85B 1.61 $102.81M $4.01 21.87
: In the previous week, Integer had 2 more articles in the media than Masimo. MarketBeat recorded 11 mentions for Integer and 9 mentions for Masimo. Masimo's average media sentiment score of 0.87 beat Integer's score of 0.02 indicating that Masimo is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Masimo
4 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Integer
3 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
: Masimo has a beta of 1.13, indicating that its stock price is 13% more volatile than the S&P 500. Comparatively, Integer has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500.
: 86.0% of Masimo shares are held by institutional investors. Comparatively, 99.3% of Integer shares are held by institutional investors. 9.7% of Masimo shares are held by insiders. Comparatively, 1.1% of Integer shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Company	Net Margins	Return on Equity	Return on Assets
Masimo	4.90%	31.33%	13.93%
Integer	7.64%	12.83%	6.51%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Masimo	0 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Integer	0 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.40

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Masimo	$1.53B	6.12	-$151.50M	-$10.54	N/A
Integer	$1.85B	1.61	$102.81M	$4.01	21.87

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Masimo	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Integer	3 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Integer beats Masimo on 10 of the 16 factors compared between the two stocks.

How does Integer compare to Baxter International?

Baxter International (NYSE:BAX) and Integer (NYSE:ITGR) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation and institutional ownership.

: 90.2% of Baxter International shares are held by institutional investors. Comparatively, 99.3% of Integer shares are held by institutional investors. 0.2% of Baxter International shares are held by insiders. Comparatively, 1.1% of Integer shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
: Integer has a net margin of 7.64% compared to Baxter International's net margin of -9.70%. Baxter International's return on equity of 16.15% beat Integer's return on equity.
Company Net Margins Return on Equity Return on Assets
Baxter International -9.70% 16.15% 5.24%
Integer 7.64% 12.83% 6.51%
: Integer has lower revenue, but higher earnings than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Baxter International $11.24B 0.80 -$957M -$2.13 N/A
Integer $1.85B 1.61 $102.81M $4.01 21.87
: Baxter International presently has a consensus price target of $19.91, indicating a potential upside of 13.95%. Integer has a consensus price target of $98.29, indicating a potential upside of 12.08%. Given Baxter International's higher possible upside, research analysts clearly believe Baxter International is more favorable than Integer.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Baxter International
3 Sell rating(s)
8 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
1.92
Integer
0 Sell rating(s)

6 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
2.40
: Baxter International has a beta of 0.62, indicating that its stock price is 38% less volatile than the S&P 500. Comparatively, Integer has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500.
: In the previous week, Baxter International had 10 more articles in the media than Integer. MarketBeat recorded 21 mentions for Baxter International and 11 mentions for Integer. Baxter International's average media sentiment score of 0.41 beat Integer's score of 0.02 indicating that Baxter International is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Baxter International
2 Very Positive mention(s)
5 Positive mention(s)
6 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Neutral
Integer
3 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company	Net Margins	Return on Equity	Return on Assets
Baxter International	-9.70%	16.15%	5.24%
Integer	7.64%	12.83%	6.51%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baxter International	$11.24B	0.80	-$957M	-$2.13	N/A
Integer	$1.85B	1.61	$102.81M	$4.01	21.87

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baxter International	3 Sell rating(s)	8 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.92
Integer	0 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.40

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baxter International	2 Very Positive mention(s)	5 Positive mention(s)	6 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
Integer	3 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Integer beats Baxter International on 11 of the 16 factors compared between the two stocks.

How does Integer compare to Teleflex?

Teleflex (NYSE:TFX) and Integer (NYSE:ITGR) are both mid-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, profitability, risk, analyst recommendations, dividends and institutional ownership.

: Integer has a net margin of 7.64% compared to Teleflex's net margin of -30.56%. Teleflex's return on equity of 14.30% beat Integer's return on equity.
Company Net Margins Return on Equity Return on Assets
Teleflex -30.56% 14.30% 7.45%
Integer 7.64% 12.83% 6.51%
: Teleflex has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500. Comparatively, Integer has a beta of 0.67, indicating that its share price is 33% less volatile than the S&P 500.
: Integer has lower revenue, but higher earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Teleflex $1.99B 2.93 -$905.64M -$20.55 N/A
Integer $1.85B 1.61 $102.81M $4.01 21.87
: 95.6% of Teleflex shares are held by institutional investors. Comparatively, 99.3% of Integer shares are held by institutional investors. 0.7% of Teleflex shares are held by company insiders. Comparatively, 1.1% of Integer shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
: Teleflex currently has a consensus price target of $133.57, indicating a potential upside of 1.27%. Integer has a consensus price target of $98.29, indicating a potential upside of 12.08%. Given Integer's stronger consensus rating and higher probable upside, analysts clearly believe Integer is more favorable than Teleflex.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teleflex
1 Sell rating(s)
6 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
2.11
Integer
0 Sell rating(s)

6 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
2.40
: In the previous week, Teleflex had 4 more articles in the media than Integer. MarketBeat recorded 15 mentions for Teleflex and 11 mentions for Integer. Teleflex's average media sentiment score of 0.73 beat Integer's score of 0.02 indicating that Teleflex is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Teleflex
3 Very Positive mention(s)
1 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Integer
3 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company	Net Margins	Return on Equity	Return on Assets
Teleflex	-30.56%	14.30%	7.45%
Integer	7.64%	12.83%	6.51%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teleflex	$1.99B	2.93	-$905.64M	-$20.55	N/A
Integer	$1.85B	1.61	$102.81M	$4.01	21.87

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teleflex	1 Sell rating(s)	6 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.11
Integer	0 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.40

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teleflex	3 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Integer	3 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Integer beats Teleflex on 9 of the 16 factors compared between the two stocks.

Get Integer News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ITGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ITGR vs. The Competition

Export

Metric	Integer	MED INSTRUMENTS Industry	Medical Sector	NYSE Exchange
Market Cap	$2.93B	$7.16B	$6.31B	$23.23B
Dividend Yield	N/A	1.72%	2.77%	4.00%
P/E Ratio	21.87	23.43	24.22	25.11
Price / Sales	1.61	57.63	528.47	24.52
Price / Cash	8.32	24.92	43.62	25.54
Price / Book	1.75	6.00	9.87	4.67
Net Income	$102.81M	$158.34M	$3.54B	$1.07B
7 Day Performance	-1.79%	3.22%	1.57%	0.52%
1 Month Performance	3.06%	7.71%	6.13%	6.86%
1 Year Performance	-26.28%	-0.58%	43.01%	30.87%

Integer Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ITGR Integer	2.454 of 5 stars	$87.70 +1.6%	$98.29 +12.1%	-26.8%	$2.93B	$1.85B	21.87	11,000	Earnings Report
BDSX Biodesix	3.5082 of 5 stars	$10.13 -4.8%	$32.50 +220.8%	+66.7%	$107.54M	$88.50M	N/A	220	News Coverage Earnings Report Analyst Forecast
ELV Elevance Health	4.4626 of 5 stars	$356.27 +3.3%	$380.42 +6.8%	-9.6%	$74.87B	$199.13B	15.15	97,100	Positive News Analyst Revision
MASI Masimo	1.4068 of 5 stars	$178.66 +0.0%	$181.17 +1.4%	+10.5%	$9.59B	$1.53B	N/A	2,200	Analyst Upgrade
BAX Baxter International	2.4385 of 5 stars	$18.53 +2.0%	$19.80 +6.9%	-43.3%	$9.38B	$11.24B	N/A	37,500	Earnings Report

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ITGR) was last updated on 5/7/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Integer (ITGR) Competitors